Minerva Neurosciences | NERV - Assets

Minerva Neurosciences reported $55.09M in Assets for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Assets Change
Acadia Pharmaceuticals ACAD:US USD 587.81M 14.68M
Adma Biologics ADMA:US USD 300.56M 3.63M
ALKERMES ALKS:US USD 1.96B 22.08M
AstraZeneca AZN:LN USD 96.48B 2.3B
Biocryst Pharmaceuticals BCRX:US USD 550M 8.59M
Dynavax Technologies DVAX:US USD 985.85M 13.49M
Esperion Therapeutics ESPR:US USD 247.94M 64.89M
GlaxoSmithKline GSK:LN GBP 60.15B 167M
Halozyme Therapeutics HALO:US USD 1.84B 23.03M
IONIS PHARMACEUT IONS:US USD 2.53B 111.9M
Marinus Pharmaceuticals MRNS:US USD 259.52M 74.68M
Minerva Neurosciences NERV:US USD 55.09M 4.67M
Neurocrine Biosciences NBIX:US USD 2.37B 225.3M
Novartis NOVN:VX USD 117.45B 1.01B
Novavax NVAX:US USD 2.26B 8.76M
Roche Holding ROG:VX 88.15B 1.42B
Takeda 4502:JP JPY 13.5T 1.08T
Vanda Pharmaceuticals VNDA:US USD 634.25M 12.46M